Clinical characteristics of controls stratified by presence of aortic valve calcification (AVC) and patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) stratified by the presence of AVC and mitral valve calcification (MVC).
| RA/SLE | ||||||
|---|---|---|---|---|---|---|
| AVC | MVC | |||||
| Absent, n = 86 | Present, n = 24 | p | Absent, n = 89 | Present, n = 21 | p | |
| Age, yrs | 46.9 ± 9.9 | 45.0 ± 7.2 | 0.30 | 44.3 ± 8.0 | 55.6 ± 9.6 | < 0.01 |
| Female gender, % | 74 (86.0) | 23 (95.8) | 0.29 | 81 (91.0) | 16 (76.2) | 0.12 |
| SBP, mmHg | 122.4 ± 17.8 | 120.0 ± 13.9 | 0.55 | 120.0 ± 15.4 | 130.4 ± 21.1 | 0.04 |
| DBP, mmHg | 76.6 ± 10.0 | 74.7 ± 8.7 | 0.41 | 75.8 ± 9.5 | 77.6 ± 10.8 | 0.49 |
| BMI, kg/m2 | 22.1 ± 3.6 | 22.2 ± 3.9 | 0.91 | 22.2 ± 3.8 | 21.6 ± 3.2 | 0.47 |
| Smoker, % | 8 (9.3) | 1 (4.2) | 0.68 | 6 (6.7) | 3 (14.3) | 0.37 |
| Hypertension, % | 18 (20.9) | 2 (8.3) | 0.23 | 12 (13.5) | 8 (38.1) | 0.02 |
| Diabetes, % | 3 (3.5) | 1 (4.2) | 1.00 | 3 (3.4) | 1 (4.8) | 0.58 |
| Hypercholesterolemia, % | 5 (5.8) | 1 (4.2) | 1.00 | 5 (5.6) | 1 (4.8) | 1.00 |
| CRP, mg/l | 12.3 ± 17.5 | 9.2 ± 8.5 | 0.32 | 9.3 ± 9.6 | 20.4 ± 25.8 | 0.04 |
| Duration of disease, yrs | 11.2 ± 8.4 | 9.0 ± 5.3 | 0.25 | 10.9 ± 7.8 | 15.7 ± 8.9 | 0.03 |
For abbreviations see Table 1.